Emergence of high colistin resistance in carbapenem resistant in Pakistan and its potential management through immunomodulatory effect of an extract from .

Carbapenem resistant has emerged as one of the most difficult to treat nosocomial bacterial infections in recent years. It was one of the major causes of secondary infections in Covid-19 patients in developing countries. The polycationic polypeptide antibiotic colistin is used as a last resort drug to treat carbapenem resistant infections.

Lipid profiles of non-diabetic healthy and ischaemic heart disease patients.

Objective: To find any difference in the fasting lipid profile in patients with history of ischaemic heart disease (IHD) and established atherosclerotic plaques on angiography and in subjects with no known history of IHD.

Study Design: Observational, cross-sectional study.

Place And Duration Of Study: Immunology Department of University of Health Sciences, Lahore, from January 2007 to January 2009.